Evidence map›Paper›PMID 24614317›Full record

ReviewNature reviews. Genetics2014

Transcriptional enhancers: from properties to genome-wide predictions.

Daria Shlyueva, Gerald Stampfel, Alexander Stark

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 833 papers.

0numbers the graph read from it
0cells of the map it votes in
833citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

833 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. UnlockingNAR genomics and bioinformatics · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. NovelbioRxiv : the preprint server for biology · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Cardiac epigenome in heart development and disease.Nature reviews. Cardiology · 2026
    Review
  20. Article

773 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Daria Shlyueva1] Research Institute of Molecular Pathology (IMP), 1030 Vienna, Austria. [2].
Gerald Stampfel1] Research Institute of Molecular Pathology (IMP), 1030 Vienna, Austria. [2].
Alexander StarkResearch Institute of Molecular Pathology (IMP), 1030 Vienna, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cellular development, morphology and function are governed by precise patterns of gene expression. These are established by the coordinated action of genomic regulatory elements known as enhancers or cis-regulatory modules. More than 30 years after the initial discovery of enhancers, many of their properties have been elucidated; however, despite major efforts, we only have an incomplete picture of enhancers in animal genomes. In this Review, we discuss how properties of enhancer sequences and chromatin are used to predict enhancers in genome-wide studies. We also cover recently developed high-throughput methods that allow the direct testing and identification of enhancers on the basis of their activity. Finally, we discuss recent technological advances and current challenges in the field of regulatory genomics.

Indexed as

GenomeAnimalsBinding SitesChromatinEnhancer Elements, GeneticEpigenesis, GeneticGenome-Wide Association StudyHumansTranscription FactorsTranscription, GeneticChromatinTranscription Factors

Identifiers

PMID24614317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.